Franklin Resources
CTKB icon

Franklin Resources’s Cytek Biosciences CTKB Stock Holding History

Franklin Resources’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$498K Buy
113,973
+103,616
+1,000% +$489K ﹤0.01% 2458
2025
Q4 		$52.3K Sell
10,357
-76,411
-88% -$355K ﹤0.01% 2979
2025
Q3 		$301K Buy
86,768
+10,180
+13% +$38.2K ﹤0.01% 2662
2025
Q2 		$260K Buy
76,588
+444
+0.6% +$1.48K ﹤0.01% 2620
2025
Q1 		$305K Sell
76,144
-107
-0.1% -$555 ﹤0.01% 2480
2024
Q4 		$495K Buy
76,251
+134
+0.2% +$798 ﹤0.01% 2294
2024
Q3 		$405K Buy
+76,117
New +$432K ﹤0.01% 2369

Other funds holding CTKB

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return